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Abstract. Despite deep convolutional neural networks boost the per-
formance of image classification and segmentation in digital pathology
analysis, they are usually weak in interpretability for clinical applications
or require heavy annotations to achieve object localization. To overcome
this problem, we propose a weakly supervised learning-based approach
that can effectively learn to localize the discriminative evidence for a
diagnostic label from weakly labeled training data. Experimental results
show that our proposed method can reliably pinpoint the location of can-
cerous evidence supporting the decision of interest, while still achieving a
competitive performance on glimpse-level and slide-level histopathologic
cancer detection tasks.
Keywords: Pathology image detection · Weakly-supervised learning ·
Computer-aided diagnosis
1 Introduction
Pathology analysis based on microscopic images is a critical task in medical
image computing. In recent years, deep learning of digitalized pathology slide
has facilitated the progress of automating many diagnostic tasks, offering the
potential to increase accuracy and improve review efficiency. Limited by com-
putation resources, deep learning-based approaches on whole slide pathology
images (WSIs) usually train convolutional neural networks (CNNs) on patches
extracted from WSIs and aggregate the patch-level predictions to obtain a slide-
level representation, which is further used to identify cancer metastases and
stage cancer [10]. Such a patch-based CNN approach has been shown to surpass
pathologists in various diagnostic tasks [5]
Off-the-shelf CNNs have been shown to be able to accurately classify or seg-
ment pathology images into different diagnostic types in recent studies [3, 9].
However, most of these methods are weak in interpretability especially for clin-
icians, due to a lack of evidence supporting for the decision of interest. During
diagnosis, a pathologist often inspects abnormal structures (e.g., large nucleus,
hypercellularity) as the evidence for determining whether the glimpsed patch is
cancerous. For CAD systems, learning to pinpoint the discriminative evidence
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can provide precise visual assistance for clinicians. Strong supervision-based fea-
ture localization methods require a large number of pathology images annotated
in pixel-level or object-level, which are very costly and time-consuming and can
be biased by the experiences of the observers. In this paper, we propose a weakly
supervised learning (WSL) method that can learn to localize the discriminative
evidence for the class-of-interest on pathology images from weakly labeled (i.e.
image-level) training data. Our contributions include: i) proposing a new CNN
architecture with multi-branch attention modules and deep supervision mecha-
nism, to address the difficulty of localizing discrete and small objects in pathology
images, ii) formulating a generalizable approach that leverages gradient-weighted
class activation map and saliency map in a complementary way to provide ac-
curate evidence localization, iii) designing a new attention module which allows
capturing spatial attention from various context, iv) quantitatively and visu-
ally evaluating WSL methods on large scale histopathology datasets, and v)
constructing a new dataset (HPLOC) based on Camelyon16 for effectively eval-
uating evidence localization performance on histopathology images.
Related Work. Recent studies have demonstrated that CNN can learn to
localize discriminative features even when it is trained on image-level annota-
tions [12]. However, these methods are evaluated on natural image datasets (e.g.,
PASCAL), where the objects of interest are usually large and distinct in color
and shape. In contrast, objects in pathology images are usually small and less
distinct in morphology between different classes. A few recent studies investi-
gated WSL approaches on medical images, including lung nodule detection and
placental ultrasound images [1]. These methods employ GAP-based class activa-
tion map and require CNNs ending with global average pooling, which degrades
the performance of CNNs as a side effect [12].
2 Methods
The overview of the framework is shown in Fig. 1. The model is trained to predict
the cancer score for a given image, indicating the presence of cancer metastasis.
In the test phase, besides giving a binary classification, the model generates a
cancerous evidence localization map and performs localization.
2.1 Cancerous Evidence Localization Networks (CELNet)
Given the object of interest is relatively small and discrete, a moderate number of
convolutional layers is sufficient for encoding locally discriminative features. As
discussed in Section 1, instances on pathology images are similar in morphology
and can be densely distributed, the model should avoid over-downsampling in
order to pinpoint the cancerous evidence from the densely distributed instances.
The proposed CELNet starts with a 3×3 convolution head followed by 3 Multi-
branch Attention-based Residual Modules (MA-ResModule) 1 [2]. Each MA-
ResModule is composed of 3 consecutive building blocks integrated with the
1 Densely connected module is not employed considering it is comparatively speed-
inefficient for WSIs application due to its dense tensor concatenation.
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Fig. 1. Left: Framework overview of the proposed WSL method. The under line
(e.g., /1, 16) denotes stride and number of channels. Right: A building block for the
multi-branch attention based residual module (MA-ResModule).
proposed attention module (MAM) as shown in Fig. 1 (Right). We use 3 × 3
convolution with stride of 2 for downsampling in residual connections instead of
1×1 convolution to reduce information loss. Batch normalization and ReLU are
applied after each convolution layer for regularization and non-linearity.
Multi-branch Attention Module (MAM) To eliminate the effect of back-
ground contents and focus on representing the cancerous evidence (which can
be sparse), we employ attention mechanism. Improved on Convolutional Block
Attention Module (CBAM) , which extracts channel attention and spatial at-
tention of an input feature map in a squeeze and excitation manner, we propose
a multi-branch attention module. MAM can better approximate the importance
of each location on the feature map by looking at its context at different scales.
Given a squeezed feature map Fsq generated by the channel attention module, we
compute and derive a 2D spatial attention map As by As = σ(
∑
k′ f
k′×k′(Fsq)),
where fk
′×k′ represents a convolution operation with kernel size of k′ × k′, and
σ denotes the sigmoid function. We set k′ ∈ {3, 5, 7} in our experiments, corre-
sponding to 3 branches. Hereby, the feature map Fsq is refined by element-wise
multiplication with the spatial attention map As.
MAM is conceptually simple but effective in improving detection and local-
ization performance as demonstrated in our experiments.
Deep Supervision Deep supervision [4] is employed to empower the interme-
diate layers to learn class-discriminative representations, for building the cancer
activation map in a higher resolution. We achieve this by adding two companion
output layers to the last two MA-ResModules, as shown in Fig. 1. Global max
pooling (GMP) is applied to search for the best discriminative features spatially,
while global average pooling (GAP) is applied to encourage the network to iden-
tify all discriminative parts on the image. Each companion output layer applies
GAP and GMP on the input feature map and concatenates the resulting vectors.
The cancer score of the input image is derived by concatenating the outputs of
the two companion layers followed by a fully convolutional layer (i.e., kernel size
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1×1) with a sigmoid activation. CELNet enjoys efficient inference when applied
to test WSIs, as it is fully convolutional and avoids repetitive computation for
the overlapping part between neighboring patches.
2.2 Cancerous Evidence Localization Map (CELM)
Cancer Activation Map (CAM) Given an image I ∈ RH×W×3, let yc =
Sc(I) represent the cancer score function governed by the trained CELNet (be-
fore sigmoid layer). A cancer-class activation map M c shows the importance of
each region on the image to the diagnostic value. For a target layer l, the CAM
M cl is derived by taking the weighted sum of feature maps Fl with the weights
{αck,l }, where αck,l represents the importance of kth feature plane. The weights
αck,l are computed as α
c
k,l = Avgi,j(
∂yc
∂Fkl (i,j)
), i.e., spatially averaging the gradi-
ents of cancer score yc with respect to the kth feature plane F kl , which is achieved
by back propagation (see Fig.1). Thus, the CAM of layer l can be derived by
M cl = ReLU(
∑
k α
c
k,lF
k
l ), where ReLU is applied to exclude the features with
negative influence on the class of interest [6].
We derive two CAMs, M c2 and M
c
3 from the last layer of the second and the
third residual module on CELNet respectively (i.e., CAM2 and CAM3 in Fig.1).
CAM3 can represent discriminative regions for identifying a cancer class in a
relatively low resolution while CAM2 enjoys higher resolution and still class-
discriminative under deep supervision.
Cancer Saliency Map (CSM) In contrast with CAM, the cancer-class saliency
map shows the contribution of each pixel site to the cancer score yc. This can
be approximated by the derivate of a linear function Sc(I) ≈ wT I + b. Thus the
pixel contribution is computed as w = ∂S
c(I)
∂I . Different from [7], we derive w
by the guided back-propagation [8] to prevent backward flow of negative gradi-
ents. For a RGB image, to obtain its cancer saliency map Ms ∈ RH×W×1 from
w ∈ RH×W×3, we first normalize w to [0, 1] range, followed by greyscale conver-
sion and Gaussian smoothing, instead of simply taking the maximum magnitude
of w as proposed in [7]. Thus, the resulting cancer saliency map (see Fig. 2 (b))
is far less noisy and more focus on class-related objects than the original one
proposed in [7].
Complementary Fusion The generated CAMs coarsely display discrimina-
tive regions for identifying a cancer class (see Fig.2 (c)), while the CSM is
fine-grained, sensitive and represents pixelated contributions for the identifica-
tion (see Fig.2 (b)). To combine the merits of them for precise cancerous evi-
dence localization, we propose a complementary fusion method. First, CAM3 and
CAM2 are combined to obtain a unified cancer activation map M c ∈ RH×W×1
as M c = αfu(M
c
3 ) + (1 − α)fu(M c2 ), where fu denotes a upsampling function
by bilinear interpolation, and the coefficient α in range [0,1] is confirmed by
validation. The CELM is derived by complementarily fusing CSM and CAM as
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M = β(M c Ms) + (1 − β)M c, where  denotes element-wise product, and
the coefficient β captures the reliability of the point-wise multiplication of CAM
and CSM, and the value of β is estimated by cross-validation in experiments.
3 Experiments & Results
We first evaluate the detection performance of the proposed model as for clinical
requirements, followed by evidence localization evaluations.
3.1 Datasets and Experimental Setup
The detection performance of the proposed method is validated on two bench-
mark datasets, PCam [9] and Camelyon16 2.
PCam: The PCam dataset contains 327,680 lymph node histopathology im-
ages of size 96 × 96 with binary class labels indicating the presence of cancer
metastasis, split into 75% for training, 12.5% for validation, and 12.5% for test-
ing as originally proposed. The class distribution in each split is balanced (1:1).
For a fair comparison, following [9], we perform image augmentation by random
90-degree rotations and horizontal flipping during training.
Camelyon16: The Camelyon16 dataset includes 270 H&E stained WSIs
(160 normal and 110 cancerous cases) for training and 129 WSIs held out for
testing (80 normal and 49 cancerous cases) with average image size about 65000×
45000, where regions with cancer metastasis are delineated in cancerous slides.
To apply our CELNet on WSIs, we follow the pipeline proposed in [5], including
WSI pre-processing, patch sampling and augmentation, heatmap generation, and
slide-level detection tasks. For slide-level classification, we take the maximum
tumor score among all patches as the final slide-level prediction. For tumor
region localization, we apply non-suppression maximum algorithm on the tumor
probability map aggregated from patch predictions to iteratively extract tumor
region coordinates. We work on the WSI data at 10× resolution instead of 40×
with the available computation resources.
In our experiments, all models are trained using binary cross-entropy loss
with L2 regularization of 10−5 to improve model generalizability, and optimized
by SGD with Nesterov momentum of 0.9 with a batch size of 64 for 100 epochs.
The learning rate is initialized with 10−4 and is halved at 50 and 75 epochs. We
select model weights with minimum validation loss for test evaluation.
3.2 Classification Results
As Tbl. 1 shows, CELNet consistently outperforms ResNet, DenseNet, and
P4M-DenseNet [9] in histopathologic cancer detection on the PCam dataset.
P4M-DenseNet uses less parameters due to parameter sharing in the p4m-
equivariance. For auxiliary experiments, we perform ablation studies and visual
2 https://camelyon16.grand-challenge.org
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analysis. From Tbl. 1 , we observe that our attention module brings 1.77% accu-
racy gain, which is larger than the gain brought by CBAM [11]. Both the CAM
and CELM on CELNet are mainly activated for the cancerous regions (see Fig.2
(c) and (d)). These subfigures indicate that CELNet is effective in extracting
discriminative evidence for histopathologic classification.
Table 1. Quantitative comparisons
on the PCam test set. P4M-DenseNet
[9]: current SoTA method for the
PCam benchmark, CELNet: our
method, −: removal of the pro-
posed multi-branch attention mod-
ule, +CBAM: integration with con-
volutional block attention module
[11].
Methods Acc AUC #Params
ResNet18 [2] 88.73 95.36 11.2M
DenseNet [9] 87.20 94.60 902K
P4M-DenseNet 89.80 96.30 119K
CELNet 91.87 97.72 297K
CELNet− 90.10 96.45 292K
CELNet− +CBAM 90.86 97.17 296K
On slide-level detection tasks, as shown in Tbl.2, our CELNet based ap-
proach achieves higher classification performance (1.7%) in terms of AUC than
the baseline method [5], and outperforms previous state-of-the-art methods in
slide-level tumor localization performance in terms of FROC score. The results
illustrate that instead of using off-the-shelve CNNs as the core patch-level model
for histopathologic slide detection, adopting CELNet can potentially bring larger
performance gain. CELNet is more parameter-efficient as shown in Tbl.1 and
testing a slide on Camelyon16 takes about 2 minutes on a Nvidia 1080Ti GPU.
Table 2. Quantitative comparisons of slide-
level classification performance (AUC) and
slide-level tumor localization performance
(FROC) on the Camelyon16 test set. *: The
Challenge Winner uses 40× resolution while
results of other methods are based on 10×.
Methods AUC FROC
P4M-DenseNet - 84.0
Liu [5] 96.5 79.3
Challenge Winner∗ [10] 99.4 80.7
Pathologist 96.6 73.3
CELNet 97.2 84.8
3.3 Weakly Supervised Localization and Results
Given that the trained CELNet can precisely classify a pathology image, here we
aim to investigate its performance in localizing the supporting evidence based on
the proposed CELM. To achieve this, based on Camelyon16, we first construct
a dataset with region-level annotations for cancer metastasis, namely HPLOC,
and develop the metrics for measuring localization performance on HPLOC.
HPLOC: The HPLOC dataset contains 20,000 images of size 96 × 96 with
segmentation masks for cancerous region. Each image is sampled from the test
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(a) Input (b) CSM (c) CAM (d) CELM (e) Localization (f) GT
Fig. 2. Evidence localization results of our WSL method on the HPLOC dataset.
(a) Input glimpse, (b) Cancer Saliency Map, (c) Cancer Activation Map, (d) CELM:
Cancerous Evidence Localization Map, (e) Localization results based on CELM, where
the localized evidence is highlighted for providing visual assistance, (f) GT: ground
truth, white masks represent tumor regions and the black represents normal tissue
set of Camelyon16 and contains both cancerous regions and normal tissue in the
glimpse, which harbors the high quality of the Camelyon16 dataset.
Metrics: To perform localization, we generate segmentation masks from
CELM/CAM/CSM by thresholding and smoothing (see Fig.2 (e)). If a segmen-
tation mask intersects with the cancerous region by at least 75% 3 , it is defined
as a true positive. Otherwise, if a segmentation mask intersects with the normal
region by at least 75%, it is considered as a false positive. Thus, we can use
precision and recall score to quantitatively assess the localization performance
of different WSL methods, where the results are summarized in Tbl.3.
Table 3. Quantitative comparisons
for different weakly supervised lo-
calization methods on the HPLOC
dataset. Ours: CELNet + CELM.
MAM and DS are short for multi-
branch attention module and deep su-
pervision respectively.
Methods Precision Recall
ResNet18 + Backprop [7] 79.8 85.5
ResNet18 + GradCAM [6] 85.6 82.4
Ours 91.6 87.3
Ours w/o MAM 88.1 85.6
Ours w/o DS 90.5 87.7
CELNet + GradCAM 91.0 85.4
We observe that our WSL method based on CELNet and CELM consis-
tently performs better than the back propagation-based approach [7] and the
class activation map-based approach [6]. Note that we used ResNet18 [2] as the
backbone for the compared methods because it achieves better classification per-
formance and provides higher resolution for GradCAM (12×12) as compared to
DenseNet (3 × 3) [9]. We perform ablation studies to further evaluate the key
components of our method in Tbl.3. We observe the effectiveness of the proposed
multi-branch attention module in increasing the localization accuracy. The deep
supervision mechanism effectively improves the precision in localization despite
slightly lower recall score, which can be caused by the regularization effect on the
intermediate layers, that is, encouraging the learning of discriminative features
3 The annotated contour in Camelyon16 is usually enlarged to surround all tumors.
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for classification but also potentially discouraging the learning of some low-level
histological patterns. We observe that using CELM can improve the recall score
and precision, which indicates that CELM allows better discovery of cancerous
evidence than using GradCAM. We present the visualization results in Fig. 2,
the cancerous evidence is represented as large nucleus and hypercellularity in
the images, which are precisely captured by the CELM. Fig.2(e) visualizes the
localization results by overlaying the segmentation mask generated from CELM
onto the input image, which demonstrates the effectiveness of our WSL method
in localizing cancerous evidence.
4 Discussion & Conclusions
In this paper, we have proposed a generalizable method for localizing cancerous
evidence on histopathology images. Unlike the conventional feature-based ap-
proaches, the proposed method does not rely on specific feature descriptors but
learn discriminative features for localization from the data. To the best of our
knowledge, investigating weakly supervised CNNs for cancerous evidence local-
ization and quantitatively evaluating them on large datasets have not been per-
formed on histopathology images. Experimental results show that our proposed
method can achieve competitive classification performance on histopathologic
cancer detection, and more importantly, provide reliable and accurate cancerous
evidence localization using weakly training data, which reduces the burden of
annotations. We believe that such an extendable method can have a great impact
in detection-based studies in microscopy images and help improve the accuracy
and interpretability for current deep learning-based pathology analysis systems.
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